Johnson Financial Group, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1477024
RACINE, WI
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$150,930
-$15,452 QoQ
Shares Held
338
-7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Johnson Financial Group, Inc. holds $3,060,900 across 22 Biotechnology names. VRTX ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,418 | $2,640,883 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,858 | $165,469 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
338 | $150,930 | |
| 4 | KLRS |
Kalaris Therapeutics, Inc.
|
10,000 | $57,700 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
687 | $22,822 | |
| 6 | INCY |
Incyte Corp
|
46 | $4,329 | |
| 7 | ENTA |
Enanta Pharmaceuticals Inc
|
188 | $2,374 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,316 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,930 | 338 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $166,382 | 367 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $253,782 | 648 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $188,764 | 424 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $525,544 | 1,084 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $849,696 | 2,110 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,438,336 | 7,393 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,236,980 | 6,906 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $432,221 | 1,034 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $407,296 | 1,001 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $339,741 | 977 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $375,487 | 1,067 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $235,987 | 749 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,493 | 161 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $46,615 | 161 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,223 | 125 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $32,621 | 125 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,450 | 125 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,673 | 125 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,203 | 125 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,861 | 125 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||